Status:

RECRUITING

PITCHER (Peritoneal Carcinomatosis Heterogeneity)

Lead Sponsor:

Hospices Civils de Lyon

Conditions:

Secondary Peritoneal Cancers

Colorectal Cancer

Eligibility:

All Genders

18+ years

Brief Summary

How epigenetic deregulation affects gene expression patterns in subclones of the same tumor is poorly known. Peritoneal Carcinomatosis (PC) is a condition in which multiple metastases of the same abdo...

Eligibility Criteria

Inclusion

  • Patients who accept to participate to the study
  • Men / women aged over 18 years
  • Patients with cancer management and care for peritoneal carcinomatosis of digestive or ovarian origin
  • Patients had histologic/radiologic confirmation of peritoneal disease
  • Serology negative HIV, HEPATITIS

Exclusion

  • • none

Key Trial Info

Start Date :

September 1 2020

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

September 1 2027

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT04714957

Start Date

September 1 2020

End Date

September 1 2027

Last Update

January 20 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Lyon SUD Hospital, Hospices Civils de Lyon

Lyon, France